Funds holding PHARMING GROUP NV
ISIN US71716E1055 · Netherlands · LEI 724500DCJ9MPG74JEH91
- Fund holders
- 3
- Of which ETFs
- 0 3 other funds
- Value held
- ≈ 318.9K $ 239.3K $ · 67.8K €
This issuer has other securities : Pharming Group NV (NL0010391025)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Steward Values Enhanced International Fund Steward Funds Inc | 12,463 | 205.1K $ | 0.07 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,093 | 34.1K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| GESTION BOUTIQUE VI, FI GESTION BOUTIQUE VI / NOAX GLOBAL ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 67.8K € | 4.00 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| GESTION BOUTIQUE VI, FI GESTION BOUTIQUE VI / NOAX GLOBAL ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 4.00 % | as of Dec 31, 2025 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 0.07 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 2 | +1 | 14,556 | +595.5 % |
| 2026Q1 | 1 | 0 | 2,093 | 0.0 % |
| 2025Q4 | 1 | 0 | 2,093 | 0.0 % |
| 2025Q3 | 1 | 0 | 2,093 | 0.0 % |
| 2025Q2 | 1 | 0 | 2,093 | 0.0 % |
| 2025Q1 | 1 | 0 | 2,093 | 0.0 % |
| 2024Q4 | 1 | 0 | 2,093 | 0.0 % |
| 2024Q3 | 1 | 0 | 2,093 | 0.0 % |
| 2024Q2 | 1 | 0 | 2,093 | 0.0 % |
| 2024Q1 | 1 | 0 | 2,093 | 0.0 % |
| 2023Q4 | 1 | 2,093 |
Institutional managers
12 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | 44,747 | 744.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 11,489 | 191.2K $ | as of Mar 31, 2026 |
| SmartHarvest Portfolios, LLC | 10,797 | 179.7K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 10,189 | 169.5K $ | as of Mar 31, 2026 |
| Knoll Capital Management, LLC | 4,057 | 67.5K $ | as of Mar 31, 2026 |
| Nalls Sherbakoff Group, LLC | 870 | 15.4K $ | as of Dec 31, 2025 |
| EverSource Wealth Advisors, LLC | 557 | 9.3K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 400 | 6.7K $ | as of Mar 31, 2026 |
| Larson Financial Group LLC | 343 | 5.7K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 128 | 2.1K $ | as of Mar 31, 2026 |
| Stone House Investment Management, LLC | 79 | 1.3K $ | as of Mar 31, 2026 |
| Cornerstone Financial Management LLC | 32 | 532 $ | as of Mar 31, 2026 |
Funds holding the debt of PHARMING GROUP NV
5 funds declare 5 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| American Beacon SiM High Yield Opportunities Fund | 1 | 10.4M $ | as of Feb 28, 2026 |
| JNL Multi-Manager Alternative Fund | 1 | 816.4K $ | as of Mar 31, 2026 |
| Lazard Enhanced Opportunities Portfolio | 1 | 494.3K $ | as of Mar 31, 2026 |
| PACE Alternative Strategies Investments | 1 | 332.9K $ | as of Apr 30, 2026 |
| Franklin Alternative Strategies Fund | 1 | 165.6K $ | as of Feb 27, 2026 |
Cite this page
Titelia. "Funds holding PHARMING GROUP NV". https://titelia.com/en/stocks/pharming-group-nv-US71716E1055